Recent emergence of serogroup C meningococcal disease in Greece

FEMS Immunology and Medical Microbiology

Volumn 23, Issue 1, 1999, Pages 49-55

  Kremastinou, Jenny ^a   Tzanakaki, Georgina ^a   Kansouzidou, Athina ^b   Pagalis, Anastasia ^c   Danielides, Vassilios ^b   Kouppari, Georgia ^d   Lada, Eleni ^e   Kriz, Paula ^f   Musilek, Martin ^f   Weir, Donald M ^g   Blackwell, C Caroline ^g  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^b Infectious Diseases Hospital of Thessaloniki   (Greece)

^c Agia Sofia Hospital   (Greece)

^d Children's Hospital Aglaia Kyriakou   (Greece)

^e Microbiology Laboratory of Pentelis   (Greece)

^f NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

ET 15 clone; Greece; Neisseria meningitidis; Phenotype; Serogroup C

Indexed keywords

CEFACLOR; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; PENICILLIN G; RIFAMPICIN; SULFADIAZINE; TETRACYCLINE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; GREECE; HUMAN; IN VITRO STUDY; MENINGOCOCCOSIS; MORTALITY; NEISSERIA MENINGITIDIS; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; GREECE; HUMANS; INFANT; INFANT, NEWBORN; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEISSERIA MENINGITIDIS; SEROTYPING;

EID: 0033048034     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(98)00120-5     Document Type: Article

References (19)

1. Krizova, P. and Musilek, M. (1995) Changing epidemiology of meningococcal invasive disease in the Czech Republic caused by a new clone of Neisseria meningitidis C:2a:P1.2 (P1.5), ET-15/37. Centr. Eur. J. Publ. Health 3, 189-194.
2. Tzanakaki, G., Blackwell, C.C., Kremastinou, J., Kallergi, C., Fallon, R.J. and Weir, D.M. (1993) Serogroups, serotypes and subtypes of Neisseria meningitidis isolated from patients and carriers in Greece. J. Med. Microbiol. 38, 19-22.
3. Tzanakaki, G., Blackwell, C.C., Kremastinou, J., Kallergi, C. and Weir, D.M. (1992) Antibiotic sensitivities of meningococcal isolates obtained from patients and carriers in Greece. Epidemiol. Infect. 108, 449-456.
4. Tzanakaki, G., Kriz, P., Kremastinou, J., Musilek, M. Smart, L.E. and Blackwell, C.C. (1997) Reactivity of the new monoclonal antibody '22' with meningococcal strains isolated from patients and carriers in Greece. FEMS Immunol. Med. Microbiol. 19, 1-5.
5. Kremastinou, J., Tzanakaki, G., Velonakis, E., Voyiatzi, A., Nickolaou, A., Elton, R.A., Weir, D.M. and Blackwell, C.C. (1998) Carriage of Neisseria meningitidis and Neisseria lactamica among ethnic Greek schoolchildren from Russian immigrant families in Athens. FEMS Immunol. Med. Microbiol. (in press).
6. Krizova, P., Musilek, M., Danielova V. and Holubova, J. (1996) New serotype candidate of Neisseria meningitidis. Centr. Eur. J. Publ. Health 4, 169-172.
7. AAC Working Party, Phillips, I., Andrews, J., Bink, A.J. et al. (1988) Breakpoints in in vitro antibiotic sensitivity testing. J. Antimicrob. Chemother. 21, 701-710.
8. Musilek, M., Giorgini, D., Hamadouche, N., Kriz, P. and Taha, M.K. (1998) Genetic heterogeneity of strains of Neisseria meningitidis belonging to serotype 22 isolated in the Czech Republic. J. Clin. Microbiol. 36, 563-565.
9. Selander, R.K., Caugant, D.A., Ochman, H., Musser, J.M., Gilmour, M.N. and Whittam, T.S. (1986) Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl. Environ. Microbiol. 51, 873-884.
10. Ashton, F.E., Ryan, J.A., Borczyk, A., Caugant, D.A., Mancino, L. and Huang, D. (1991) Emergence of a virulent clone of Neisseria meningnidis serotype 2a that is associated with meningococcal group C disease in Canada. J. Clin. Microbiol. 29, 2489-2493.
11. Kriz, P., Vlckova, J. and Bobak, M. (1995) Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic. Epidemiol. Infect. 115, 411-418.
12. Krizova, P., Musilek, M. and Kalmusova, J. (1997) Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37. Centr. Eur. J. Publ. Health 5, 214-218.
13. Schoenbach, E.B. and Phair, J.J. (1948) The sensitivity of meningococci to sulfadiazine. Am. J. Hyg. 47, 177-186.
14. Love, D.B. Jr. and Finland, M. (1954) In-vitro susceptibility of meningococci to eleven antibiotics and sulfadiazine. Am. J. Med. Sci. 228, 534-539.
15. Andersen, B.M. (1979) Mortality in meningococcal infections. Scand. J. Infect. Dis. 10, 277-282.
16. Bovre, J. and Gedde-Dahl, T.W. (1980) Epidemiological patterns of meningococcal disease in Norway 1975-1979. Natl. Inst. Publ. Health Ann. 43, 9-23.
17. Peltola, H. (1983) Meningococcal disease: Still with us. Rev. Infect. Dis. 5, 71-91.
18. Kuzemenska, P. and Kriz B. (1987) Epidemiology of meningococcal disease in Central and Eastern Europe. In: Evolution of Meningococcal Disease (Vedros, N.A., Ed.). Vol. I, pp. 103-137. CRC Press, Boca Raton, FL.
19. Caugant, D.A., Kremastinou, J., Tzanakaki, G., Mihalcu, F. and Blackwell, C.C. (1994) Characteristics of meningococcal isolates from patients and carriers in the Balkans. In: Neisseria 94 (Evans, J.S. et al., Eds.), pp. 391-392. SCC, London.